InvestorsHub Logo

boozeman

11/18/19 12:23 PM

#227813 RE: mrmainstreet #227808

I was until today, thought the short thesis was gone and we could hold gains. Articles painting Evaporate as a failure do not sit well for the pps after the run up we have had to get, in my book, to a fair value. There is a lot of time between now and patent settlement, so it looks like Citi and GS will be back in full force. Good luck all.

KCSVEN

11/18/19 12:42 PM

#227826 RE: mrmainstreet #227808

So much more comfortable. I feel like we won. No real fear at all now, stock is worth $25, so what can they take it down to? And I said in multiple posts was expecting unanimous Adcom but still way more comfortable now that it is over, De-Risk!

We know label is getting expanded and a large population regardless of details.

Generics will have more movement mid-December and to date all points positively for Amarin.

Of course they need to prove they can do a billion in sales and fast. Need to show peak sales will be higher than Citi estimated.

But all that seems likely, will we be in the $30's this year? Doubt it, but they execute then next year looks possible, BO price is at least $41 now, maybe as high as $51. So pretty confident 30's next year GIA and $40 minimum BO. Not a lot of scenarios where price is lower 6 months from now than it is now.

Let the momentum traders have their fun.

I sold this week's 27 calls, will keep selling calls as I feel comfortable. I think when smoke clears institutions will take positions and $25 is the price it will hover around so selling calls 25-27 probably the sweet spot.

amarinbullfromchicago

11/18/19 12:44 PM

#227827 RE: mrmainstreet #227808

I sold some of those on Friday actually, not at day highs per se but I was happy with them (88c I think average on 500 calls). Don’t think we jump much higher till new year

chas1232123

11/18/19 1:13 PM

#227847 RE: mrmainstreet #227808

MrM - Keep in mind FDA probably doesn't want to do anything during the holidays, so very possible they approve by Dec 20, and IMO unlikely the label doesn't include at least diabetics with elevated risk as per ADA. (It ought to include a lot more, and may well.)

sts66

11/18/19 3:44 PM

#227898 RE: mrmainstreet #227808

I never had any problem sleeping because unlike some people here my financial future isn't dependent on what happens to my AMRN stock......a BO at $50 would be great, but not a life changer.....